“Trust us.”
This was the gist of Google’s response to reports that the company has obtained access to detailed medical records on tens of millions of Americans through a partnership with Ascension, the United States’ second-largest health care system.
Recent history suggests there is plenty of reason to be skeptical of Google and its project with Ascension, code-named Nightingale.
The partnership has afforded Google access to the health records of some 50 million Ascension patients. The information includes, for starters, names, birth dates, addresses, allergies, immunizations, lab tests, medications, medical conditions and billing claims.
What’s more, Google and Ascension began the project in secret last year, according to The Wall Street Journal, and neither doctors nor patients were formally notified of the arrangement.
Google has promised not to mix medical data with the treasure trove of data it otherwise collects from consumers. It also insists that it will adhere to medical privacy law, like the Health Insurance Portability and Accountability Act, as it works on the Nightingale project.
There may well be useful applications for this data. Google could use the information to design software reliant on artificial intelligence and machine learning that improves medical care, facilitating more accurate diagnoses and impactful treatments. Google, which is not being paid by Ascension, a nonprofit, could then spin off its work into programs to be sold to other health care providers.
The fact remains, nonetheless, that Google and its staff now have access to the medical records of nearly 50 million patients, and it secured that access without ever having to obtain permission. Ascension bears primary responsibility for this failure; it should have contacted patients and doctors about the partnership. But Google seems to have had no reservation about proceeding without the permission of patients.
When coupled with Google’s poor record on privacy — a record that includes tens of millions of fines for violating the European Union’s General Data Protection Regulation — its access becomes doubly concerning, as Ascension patients must now wonder who is studying their medical records and who else could gain access to that information without their knowledge.
The Office for Civil Rights at the U.S. Department of Health and Human Services announced Nov. 13 that it “would like to learn more information about this mass collection of individuals’ medical records with respect to the implications for patient privacy under HIPAA.” This is a promising development. There are so many privacy scandals of so many varieties, the American public has become somewhat numb. However, the sensitivity of the medical records Google has obtained demands extra scrutiny.
Google and Ascension should also act of their own volition to provide patients with an option either to opt in or opt out of the data sharing. Ascension patients did not know their personal information, shared privately with medical professionals, would end up being studied by engineers and researchers in Silicon Valley. Those patients deserve the agency to decide whether their data remains accessible to Google.
Time will tell if Google can respectfully and securely handle and study this highly sensitive data. The company has been a failed steward of privacy, choosing to pay fines rather than right its wrongs. Lawmakers and regulatory agencies should carefully monitor all developments in Google’s relationship with Ascension then take action if necessary to protect the privacy of those who have become unwilling pawns in Google’s business strategy.



Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.